healthcare.digital September 29, 2024
Exec Summary:
The combination of technological advancements, regulatory changes, market dynamics, and increased investor interest is driving healthtech M&A valuations to new heights. Companies with innovative technologies, strong market positions, and the potential to address significant healthcare challenges are likely to be highly valued in today’s M&A market.
In terms of valuation, the 10 Key Variables in HealthTech M&A valuation multiples today are:
Stage of the company’s development: Early-stage companies are typically valued at a lower multiple than more mature companies.
Size of the company: Larger companies are typically valued at a higher multiple than smaller companies.
Intellectual property portfolio: Companies with valuable intellectual property are typically valued at a...
Today's Sponsors
Today's Sponsor